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Schizophrenia (SZ) is a neurodevelopmental disorder. There remain significant gaps in understanding the neural trajectory across
development in SZ. A major research focus is to clarify the developmental functional changes of SZ and to identify the specific
timing, the specific brain regions, and the underlying mechanisms of brain alterations during SZ development. Regional
homogeneity (ReHo) characterizing brain function was collected and analyzed on humans with SZ (hSZ) and healthy controls (HC)
cross-sectionally, and methylazoxymethanol acetate (MAM) rats, a neurodevelopmental model of SZ, and vehicle rats longitudinally
from adolescence to adulthood. Metabolomic and proteomic profiling in adult MAM rats and vehicle rats was examined and
bioanalyzed. Compared to HC or adult vehicle rats, similar ReHo alterations were observed in hSZ and adult MAM rats, characterized
by increased frontal (medial prefrontal and orbitofrontal cortices) and decreased posterior (visual and associated cortices) ReHo.
Longitudinal analysis of MAM rats showed aberrant ReHo patterns as decreased posterior ReHo in adolescence and increased
frontal and decreased posterior ReHo in adulthood. Accordingly, it was suggested that the visual cortex was a critical locus and
adolescence was a sensitive window in SZ development. In addition, metabolic and proteomic alterations in adult MAM rats
suggested that central carbon metabolism disturbance and mitochondrial dysfunction were the potential mechanisms underlying
the ReHo alterations. This study proposed frontal-posterior functional imbalance and aberrant function developmental patterns in
SZ, suggesting that the adolescent visual cortex was a critical locus and a sensitive window in SZ development. These findings from
linking data between hSZ and MAM rats may have a significant translational contribution to the development of effective
therapies in SZ.
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INTRODUCTION
Schizophrenia (SZ) is a neurodevelopmental disorder that typically
manifests between late adolescence to young adulthood [1]. Brain
alterations in SZ likely reflect both pathological and compensatory
processes over a protracted developmental period [2, 3], and
further underscore the importance of developmental neuroplas-
ticity in SZ from infancy to adulthood [4]. During this critical
period, cortical circuits mature via rearrangement processes,
including myelination, synaptic pruning, and dendritic plasticity
[5], as well as the maturation of neurotransmitter systems,
including the glutamatergic, the dopaminergic, and the GABAer-
gic systems [6]. In SZ, as high-risk states convert to psychosis,
neural alterations appear to accumulate and progress from early
development onwards, and brain disruptions become widespread
and global in adulthood [7, 8]. However, there remain significant
gaps in understanding the dynamic brain changes across
development in SZ, and it is unclear what are the specific timing,
the specific brain regions, and the underlying mechanisms of
brain alterations during SZ development.
Animal models may offer important insights to address these
knowledge gaps. The major animal models of SZ contained
neurodevelopmental, pharmacological, lesion, and genetic models
[9, 10]. One such model employs the administration of a mitotoxin,
methylazoxymethanol acetate (MAM), during gestation to induce
a developmental disruption [11]. At gestational day 17 (E17),
through selective disturbance of proliferation and migration of
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neuronal precursor cells undergoing their final mitosis, MAM
induces morphological and cytological alterations on developing
paralimbic, frontal, and temporal cortices, regions where deficits
are typically observed in SZ patients [12, 13]. Moreover, rats
exposed to MAM on E17 have neuroanatomical, neuronal
processing, and behavioral alterations similar to SZ, and thus
may serve as a neurodevelopmental animal model of SZ [10, 14].
MAM rats have shown reduced size, increased neuronal density,
and impaired synaptic activity in the prefrontal and anterior
cingulate regions, and reduced size, decreased neuropil, and
disordered neuronal cytoarchitecture in the occipital regions
[12, 15]. Similarly, significantly decreased gray matter volumes in
the orbitofrontal, anterior cingulate, and occipital regions have
been found in human with SZ (hSZ) [16]. The similarity of
abnormal neuronal synchronization in hSZ and MAM rats has also
been observed. Deficits in gamma activity during SZ relevant
cognitive tasks and increased background gamma activity have
been found in MAM rats, similar to gamma activity patterns
observed in hSZ [17, 18]. Interestingly, the functional imbalance
between frontal and posterior brain regions has also been found
in both MAM rats and hSZ by functional magnetic resonance
imaging (fMRI). MAM rats have shown lower functional con-
nectivity (FC) in the orbitofrontal cortex (OFC) and higher FC in the
visual cortex, as well as a higher number of long-range
connections, and a lower number of short-range connections
[19]. Our group previously demonstrated hyperactivity indexed by
amplitude of low-frequency fluctuations (ALFF) in the prefrontal
cortex (PFC) and hypoactivity in the primary sensory cortices [20],
as well as increased medium/long-range connectivity in the PFC
and decreased short-range connectivity in the primary sensory
cortices [21]. In light of their structural and functional similarities,
MAM rats could serve as a neurodevelopmental model for brain
organization and function in hSZ.
Several neuroimaging measures have been proposed as
potential biomarkers of spatial and temporal dynamics in SZ
[22]. Regional homogeneity (ReHo) is a commonly used measure
that reflects spontaneous local activity within individual regions. It
employs Kendall’s coefficient of concordance (KCC) to measure
the temporal similarity of local blood–oxygen-level-dependent
(BOLD) signals [23]. ReHo appears dependent on a combination of
anatomical, developmental, and neurocognitive factors [24] and
has been successfully employed to examine changes or modula-
tions under different conditions across the whole brain in a voxel-
by-voxel manner and detect disease-associated regional activity
changes [25]. It is a highly sensitive, reproducible, and reliable
index in SZ [26], which could serve as a marker of changes in brain
dynamics and function in SZ.
This study was conducted in three major steps. Firstly, we
identified similar ReHo alterations in adult hSZ and MAM rats.
Then, we characterized the longitudinal ReHo changes from
adolescence to adulthood in MAM rats. Finally, we examined the
metabolomic and proteomic profiles in adult MAM rats to explore
the potential mechanisms for the ReHo alterations in SZ.
MATERIALS AND METHODS
Study design
The cohort of human subjects included 40 hSZ with first-episode untreated
SZ with illness duration less than two years and 42 healthy controls (HC)
between 18 and 50 years old. hSZ were recruited from inpatient and
outpatient services in the Department of Psychiatry at the First Hospital,
China Medical University and Shenyang Mental Health Center, and HC
from the local community of Shenyang. This study was approved by the
Institutional Review Board of China Medical University. Written informed
consent was obtained from each participant. The absence or presence of
Axis I disorder was confirmed using the Structured Clinical Interview for
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-
IV) via consensus between two experienced psychiatrists. HC did not have
current or lifetime Axis I disorders and any first-degree relatives with a
history of Axis I disorders. Participants were excluded if had the following
conditions: concomitant major medical disorder, neurological disease or
head injury with loss of consciousness, and/or substance/alcohol abuse or
dependence. Symptoms and cognitive measures were obtained using the
Brief Psychiatric Rating Scale (BPRS) and the Wisconsin Card Sorting Test
(WCST). fMRI scanning was performed in each participant (Fig. 1A).
The first cohort of animals consisted of 12 MAM rats and 11 vehicle rats.
MAM rats or vehicle rats were male offspring of adult pregnant
Sprague–Dawley rats (VITAL RIVER Laboratories, Beijing, China) which
were randomly administered either 22mg/kg MAM or 0.9% saline solution
intraperitoneally on E17 [27]. Animals were weaned on postnatal day (PD)
21 and rehoused with a density of 2–4/cage. Animals were in 12-h light/
dark cycle (lights on 7 am, lights off 19 pm) with the temperature at 21 ±
1 °C and humidity at 30‒70%, and ad libitum access to both food and
water. Longitudinal behavioral and fMRI assessments were examined at
two developmental points. fMRI was scanned in adolescence (PD21–25)
and adulthood (PD63–67). Open field test (OFT) and Morris water maze
(MWM) were tested first in adolescence (PD32–39), and then again in
adulthood (PD78–85) (Fig. 1B).
The second cohort of animals consisted of six MAM rats and six vehicle
rats. Regional brain tissue samples were collected in adulthood (PD73),
which were applied for metabolomic and proteomic profiling and analysis
(Fig. 1C). All procedures with animals were performed in strict accordance
with the guidelines of the Animal Care and Use Committee at Wuhan
Institute of Physics and Mathematics, Chinese Academy of Sciences.
Human MRI data acquisition and processing
All participants underwent fMRI scanning with a GE Signa HD 3.0 T scanner
(GE Healthcare, USA) with a standard 8-channel head coil at the First
Affiliated Hospital of China Medical University. Functional images were
collected using a gradient echo-planar imaging (EPI) sequence with the
following parameters: repetition time (TR)= 2000ms, echo time (TE)=
30ms, flip angle= 90°; field of view (FOV)= 240 × 240mm2; matrix= 64 ×
64; slice= 35; voxel size= 3mm3; slice thickness= 3mm without a gap.
Each participant was instructed to stay awake, close eyes, relax, and
minimize thinking during scanning.
All fMRI Images were preprocessed using the Statistical Parametric
Mapping 8 (SPM8, http://www.fil.ion.ucl.ac.uk/spm) and Data Processing
Assistant for fMRI (DPARSF, http://www.restfmri.net/forum/DPARSF) V2.3
[28]. The first ten time points were discarded due to magnetic saturation
effects. The subsequent preprocessing steps included slice time correction
and head motion correction. Images from participants with excessive
motion (>3mm of motion and/or 3° rotation) were excluded. Next, the
corrected functional images were normalized to Montreal Neurological
Institute space using the EPI template in SPM8 and resampled to 3 × 3 ×
3mm3. Further, a linear detrend was performed to reduce the influence of
increased MRI equipment temperature. Then nuisance regression was
carried out with several confounding covariates, including the Friston-24
head motion and the polynomial trend. Finally, temporal band-pass
filtering (0.01–0.08 Hz) was applied to the regressed fMRI images.
Individual ReHo maps were generated by calculating the KCC, which was
used to measure the similarity of the time series for a given voxel to
neighboring 26 voxels in a 3 × 3 × 3 space. KCC values were computed into
ReHo z-value (zReHo) by subtracting the mean voxel-wise ReHo obtained
for the entire brain. All zReHo maps were spatially smoothed with a 6 mm
full-width-at-half-maximum (FWHM) Gaussian kernel, generating the final
smoothed zReHo (szReHo) maps.
Animal behavioral assessment
The assessment methods of the OFT and MWM were reported previously
[29]. The detailed descriptions were summarized in Supplementary data.
Animal MRI data acquisition and processing
The rats were anesthetized (2% isoflurane) and secured into a head
restrainer with a built-in coil and a body tube. Isoflurane (0.5–1.0%) in a
mixture of 30% O2/70% N2 was delivered through a nose cone and the
whole system was placed into the magnet. The respiratory rate and body
temperature were monitored using a PC-SAM Small Animal Monitor (SA
Instruments, USA). The core temperature of each animal was maintained at
37 ± 0.5 °C with a heating bed. Image acquisition system consisted of a
7.0 T MRI scanner (Bruker Biospin, German) and a rat brain quadrature
surface coil (50mm diameter). fMRI data were acquired using interleaved
snapshot EPI, with the following parameter: TR= 1000ms, TE= 14ms,
matrix size= 64 × 64, FOV= 2.4 × 2.4 cm2, slice number= 20, slice
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thickness= 0.8 mm, and in-plane resolution= 375 × 375 μm. A total of 300
frames were acquired for each experimental run. A Rapid Imaging with
Refocused Echoes sequence was used for anatomical scans with TR of
5000ms, TE of 12ms, matrix size of 256 × 256, and resolution of 93.75 ×
93.75 μm. The other parameters were as that of fMRI.
Preprocessing was performed using Data Processing & Analysis of Brain
Imaging (DPABI, rfmri.org/DPABI) V3.0 rat module. A standard anatomical
rat template, spatially aligned to a Paxinos–Watson rat brain template, was
offered and authorized [30]. First, the voxel dimensions of both anatomical
and functional images were scaled by a constant (10) to fit the standard
neuroimaging software. Second, skull stripping was operated to the
anatomical images of each adolescent or adult rat in order to remove the
MRI signal outside the brain. Third, anatomical image of each rat was
normalized to the standard anatomical rat template. The anatomical
landmarks, including anterior commissure, fornix, posterior commissure,
lateral habenular nucleus, aqueduct, paraflocculus, and pyramidal tract,
were manually identified in both the template and adolescent or adult rat.
If the landmarks did not align between the template and studied rat, the
rat was removed. Fourth, functional images were applied with the
normalized anatomical image itself. This self-specific normalization is
effective in minimizing systematic errors [31]. Then functional images were
processed following slice-timing correction, motion correction, spatial
normalization, nuisance regression with 24 head motion parameters, and
0.01–0.08 Hz band-pass filter. For each animal and scan, fMRI data without
spatial smoothing were used for ReHo calculation. Individual ReHo maps
were generated by measuring the KCC. All ReHo maps were computed and
standardized into zReHo maps and then dividing the resultant value by the
standard deviation. The final szReHo maps were generated by spatially
smoothing of zReHo maps with an FWHM of 6mm.
Animal metabolomic profiling
On PD73, the brains of rats were obtained and the targeted cortices
(prefrontal and occipital cortices) were located and dissected with the
guide of brain maps 4.0 [32]. In brief, the metabolites were extracted from
the brain samples and injected into an ultra-performance liquid
chromatography system (Agilent Technologies, USA) coupled to a
quadrupole time-of-flight mass spectrometer (AB Sciex, USA) with
electrospray ionization in positive and negative ionization modes. The
metabolites were separated using an Acquity BEH C18 column (Waters,
Ireland). Total ion current, chromatographic peaks and retention times
were obtained. The raw data were converted to MzXML files. Compound
identification of the metabolites was performed by precise mass matching
(<25 ppm). The secondary spectrum diagram was matched to a self-built
database with authentic standards. After filtering and normalizing, the
processed data were uploaded into MetaboAnalyst software for further
analysis (www.metaboanalyst.ca). The detailed methods of metabolomic
profiling were illustrated in Supplementary data.
Animal proteomic profiling
The methods of sample preparation for proteomic analysis were reported
in Supplementary data. The prepared samples were performed on a Q
Exactive mass spectrometer that was coupled to Easy nanoLC (Thermo
Scientific, USA). Samples were loaded onto a reverse-phase trap column
(Thermo Scientific, USA) connected to the C18-reversed-phase analytical
column (Thermo Scientific, USA) in buffer A (0.1% formic acid) and
separated with a linear gradient of buffer B (84% acetonitrile and 0.1%
formic acid). The MS data were analyzed using MaxQuant software version
1.3.0.5 (Max Planck Institute of Biochemistry, Germany). The cutoff of
Fig. 1 Flow diagram of the study design. A We confirmed the frontal-posterior functional imbalance of SZ by comparison of ReHo using
cross-sectional fMRI data of hSZ and HC. The frontal-posterior functional imbalance was characterized by increased frontal (frontal cortices)
and decreased posterior (visual and associated cortices) ReHo. BWe determined the aberrant function developmental patterns with respect to
the timing and localization of major ReHo changes from adolescence to adulthood using longitudinal design in MAM rats. The aberrant
function developmental patterns were characterized by primarily decreased posterior ReHo in adolescence and subsequently decreased
posterior and increased frontal ReHo in adulthood. C We analyzed brain metabolomic and proteomic profiles from a cross-sectional cohort of
MAM rats and vehicle rats. Metabolic and proteomic changes in MAM rats suggested the potential mechanisms underlying the ReHo
alterations in adulthood, including central carbon metabolism disturbance and mitochondrial dysfunction. SZ schizophrenia, hSZ human with
schizophrenia, HC healthy control, fMRI functional magnetic resonance imaging, ReHo regional homogeneity, MAM methylazoxymethanol
acetate, KEGG Kyoto Encyclopedia of Genes and Genomes.
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global false discovery rate (FDR) for peptide and protein identification was
set to 0.01. Label-free quantification was carried out in MaxQuant. Protein
abundance was calculated on the basis of the normalized spectral protein
intensity. The mass spectrometry results were forwarded to statistical
analysis. The detailed methods of proteomic profiling were illustrated in
Supplementary data.
Statistical analysis
For human fMRI data, SPM8 was used to perform voxel-based two-sample t
tests to compare ReHo between HC and hSZ, with diagnostic group as an
independent factor, and age and sex as covariates. Multiple comparisons
were performed using Gaussian random field theory correction (GRF) in
DPABI V4.3 (voxel P < 0.01, cluster P < 0.05). We extracted ReHo value of the
clusters that had been shown differences between HC and hSZ. Two-
sample t tests were performed to determine the differences in ReHo value
between HC and hSZ. The significance level was set at P < 0.05. To test for
inter-group differences in demographic data and clinical characteristics of
human participants, two-sample t tests or chi-squared tests were
performed using SPSS 16.0 statistical software package (SPSS, Chicago,
IL). Statistical significance was set at P < 0.05.
For animal longitudinal fMRI data, all ReHo maps of vehicle and MAM
rats in the two scanned ages (adolescence and adulthood) were then
forwarded to two-sample t-tests. Multiple comparisons across voxels were
controlled through GRF correction (voxel P < 0.05, cluster P < 0.05).
According to results from ReHo analyses in human and rats, we defined
two ROIs. The frontal ROI included three subareas: mPFC, OFC, and ACC,
and the posterior ROI included three subareas: visual cortex, auditory
cortex, and temporal association cortex. We extracted ReHo value from the
overlaps between frontal and posterior ROIs and the clusters identified in
voxel-based tests. Post hoc analyses were performed (vehicle in
adolescence vs MAM in adolescence, and vehicle in adulthood vs MAM
in adulthood) in the two ROIs using two-sample t tests. P < 0.05 was
considered as statistical significance.
For animal behavioral data, the detailed statistical analyses were
described in Supplementary data.
For animal metabolomic data, principal component analysis and partial
least square discriminant analysis (PLS-DA) were performed for both
positive and negative models after log transformation and Pareto-scaling.
The variable importance in the projection (VIP) value of each variable in the
PLS-DA model was calculated to indicate its contribution to the
classification. Metabolites with the VIP value > 1 were further statistical
analysis. Two-sample t tests were applied to measure the significances of
each metabolite between MAM rats and vehicle rats. P < 0.05 were
considered as statistical significance. KEGG (Kyoto Encyclopedia of Genes
and Genomes) pathway analysis based on the differential metabolites was
conducted to identify the important disturbed metabolomic pathways
between vehicle and MAM rats. Functional pathways with P < 0.05 were
considered as statistical significance. The FDR was used for P values in
multiple tests.
For animal proteomic data, two-sample t tests were further applied to
measure the significance of each protein between vehicle and MAM rats.
P < 0.05 were considered as statistical significance. Significantly differential
proteins were defined as ≥1.5-fold changes. KEGG pathway analysis based
on the differential proteins was conducted to identify the important
disturbed proteomic pathways between vehicle and MAM rats. Functional
categories and pathways with P < 0.05 were considered as statistical
significance.
RESULTS
Frontal-posterior functional imbalance in hSZ
The demographic information and clinical features were pre-
sented in Supplementary Table 1. Significant differences were
observed in BPRS scores and WCST scores between hSZ and HC
(P < 0.05).
Frontal-posterior functional imbalance characterized by increased
frontal and decreased posterior ReHo were found in hSZ, compared
to HC. Significant differences in ReHo were observed in multiple
cortical regions (Supplementary Table 2), increased ReHo in
heteromodal, limbic, and paralimbic cortical regions, including
bilateral dorsal lateral PFC, bilateral OFC, bilateral anterior cingulate
cortices (ACC), bilateral paracingulate gyri, bilateral hippocampus,
bilateral parahippocampal gyri, bilateral temporal poles, and
subcortical regions, including the left caudate nucleus, while
decreased ReHo in the primary sensory cortices, including bilateral
occipital gyri, bilateral cuneus, bilateral precuneus, bilateral lingual
gyri, bilateral calcarine cortices, bilateral temporal gyri, and bilateral
postcentral gyrus (P < 0.01, Fig. 2A, B).
Aberrant developmental patterns of brain function from
adolescence to adulthood in MAM rats
Generally, compared to vehicle rats, MAM rats exhibited anxiety-
like behavior state in adolescence, and impaired spontaneous
locomotor activity, anxiety-like behavior state, cognitive deficits in
reference memory, and impairment in spatial learning ability in
adulthood, which was detailed in Supplementary Figs. 1–3.
In adolescence, MAM rats had significantly decreased ReHo in
the posterior regions, including left auditory cortex, left temporal
association cortex, left visual cortex, left entorhinal cortex, left
somatosensory cortex, bilateral amygdala, and bilateral hippo-
campus, compared to vehicle rats (Fig. 3A) (Supplementary Table
3). In adulthood, MAM rats had significantly increased ReHo in
frontal regions, including bilateral medial prefrontal cortices
(mPFC), bilateral OFC, bilateral nucleus accumbens, and bilateral
striatum, and significantly decreased ReHo in posterior regions,
including left visual cortex, left auditory cortex, left temporal
association cortex, and bilateral hippocampus, compared to
vehicle rats (Fig. 3B) (Supplementary Table 4).
Fig. 2 Frontal-posterior functional imbalance in hSZ. A Frontal-posterior functional imbalance was found in hSZ compared to HC,
expressing as decreased posterior (primary sensory cortices) and increased frontal (higher order frontal cortices) ReHo. B ReHo value was
extracted from significant clusters identified in the voxel-based test of hSZ vs. HC. Frontal-posterior functional imbalance illustrated as
increased frontal ReHo to decreased posterior ReHo from Cluster 1 to Cluster 7. A Significant at voxel P < 0.01, cluster P < 0.05 corrected by GRF
correction; B significant at P < 0.05, *P < 0.05, **P < 0.01, ***P < 0.001. SZ schizophrenia, hSZ human with schizophrenia, HC healthy control,
ReHo regional homogeneity.
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Two ROIs were defined based on results from ReHo analyses in
humans and rats: (1) The frontal ROI included three subareas:
mPFC, OFC, and ACC, and (2) the posterior ROI included three
subareas: visual cortex, auditory cortex, and temporal association
cortices. For post hoc comparisons, ReHo value was extracted
from the overlaps between the frontal and posterior ROIs and the
significant clusters identified in the longitudinal analysis of MAM
rats. Compared to vehicle rats, MAM rats had significantly
decreased ReHo value within the posterior overlap in adolescence
(T=−3.241, P= 0.004) (Fig. 3C). In adulthood, ReHo value was
D. Sun et al.
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significantly increased within the frontal overlap (T= 3.364, P=
0.004) and significantly decreased within the posterior overlap in
MAM rats (T=−5.694, P < 0.001), compared to vehicle rats
(Fig. 3C). MAM rats demonstrated aberrant developmental
evolution in brain function from primarily decreased posterior
ReHo in adolescence to further decreased posterior ReHo along
with increased frontal ReHo in adulthood.
The findings supported that shared frontal-posterior functional
imbalance between hSZ and adult MAM rats. The longitudinal
ReHo changes from adolescence to adulthood in MAM rats may
simulate neurodevelopmental patterns in hSZ. Moreover, the
visual cortex was a common brain region of ReHo alterations in
hSZ and adolescent MAM rats and adult MAM rats, and ReHo
alterations in posterior regions including the visual cortex in
adolescence appeared to precede further progression in a frontal-
posterior functional imbalance in adulthood. Altogether, it
supported that the visual cortex was a critical locus and
adolescence was a sensitive window in SZ development, which
has the neuromodulatory potential for frontal-posterior functional
imbalance in MAM rats.
Potential mechanisms of frontal-posterior functional
imbalance in MAM rats
In the brain tissue metabolomic analysis, a total of 44,766
metabolic features were detected, including 26,045 in positive
ion mode and 18,721 in negative ion mode. The statistical
analysis of internal standard peak intensity of all samples showed
sufficient repeatability (relative standard deviation < 30%), per-
mitting further analysis. Significant differences between MAM
rats and vehicle rats were found in 66 metabolites in the PFC and
90 metabolites in the occipital cortex (OC). The KEGG pathway
detected “Central carbon metabolism disturbance” both in the
PFC and OC of MAM rats (Fig. 4A, B). Moreover, in the PFC,
L-Glutamate, L-Glutamine, D-Fructose 1,6-bisphosphate, L-Alanine,
L-Aspartate, L-Malic acid, phosphoenolpyruvate, and L-Histidine
were disturbed, covering glycolysis and gluconeogenesis, citrate
cycle, alanine, aspartate and glutamate metabolism, glycine,
serine and threonine metabolism, arginine biosynthesis, glycer-
ophospholipid metabolism, and pentose phosphate pathways
(Supplementary Table 5). In the OC, L-Glutamine, L-Valine,
L-Aspartate, Citrate, and L-Histidine were disturbed, covering
citrate cycle, alanine, aspartate, and glutamate metabolism and
pentose phosphate pathways (Supplementary Table 5). These
results suggest disturbances in central carbon metabolisms as
potential mechanisms for frontal-posterior functional imbalance
in MAM rats.
In brain tissue proteomic analysis, 165 proteins in the PFC and
27 proteins in the OC showed differential expression between
MAM rats and vehicle rats. When comparing MAM rats with
vehicle rats, the altered proteins of the PFC were enriched in the
“Alzheimer disease pathway” (Fig. 4C), containing proteins related
to mitochondrial dysfunction (Supplementary Fig. 4). There was no
significant pathway in the OC. These results suggest that altered
mitochondrial function in the PFC may contribute to frontal-
posterior functional imbalance in MAM rats.
DISCUSSION
In this study, we found a similar frontal-posterior functional
imbalance between hSZ and MAM rats, characterized as increased
frontal ReHo (frontal cortices), and decreased posterior ReHo
(visual and associated cortices). Longitudinal analysis of brain
function changes in MAM rats revealed that aberrant functional
patterns progressed from adolescence to adulthood: primarily
decreased posterior ReHo (visual and associated cortices) to
further decreases in posterior ReHo and increased frontal ReHo.
Accordingly, it supported that the visual cortex was a critical locus
and adolescence was a sensitive window in SZ development,
which has the neuromodulatory potential for frontal-posterior
functional imbalance in MAM rats. In addition, metabolic and
proteomic changes suggested the potential mechanisms under-
lying ReHo alterations in adulthood, including central carbon
Fig. 3 Aberrant function developmental patterns in MAM rats. A In adolescence, MAM rats showed significantly decreased ReHo in the
posterior region (visual and associated cortices). B In adulthood, MAM rats showed significantly increased ReHo in the frontal region (frontal
cortices) and decreased ReHo in the posterior region (visual and associated cortices). C ReHo value was extracted from the overlaps between
the frontal and posterior ROIs and the clusters identified in voxel-based tests of animal longitudinal study. In adolescence, ReHo value of MAM
rats was significantly decreased in the posterior overlap, compared to vehicle rats. In adulthood, ReHo value of MAM rats was significantly
increased in the frontal overlap and significantly decreased in the posterior overlap, compared to vehicle rats. A, B Significant at voxel P value
< 0.05, cluster P value < 0.05 corrected by GRF correction; C significant at P < 0.05, *P < 0.05, **P < 0.01, ***P < 0.001; the frontal ROI contains
three subareas: the medial prefrontal cortex, orbitofrontal cortex, and anterior cingulate cortex; the posterior ROI contains three subareas:
visual cortex, auditory cortex, and temporal association cortex; posterior, the overlaps between the posterior ROI and the clusters in the
posterior region identified in voxel-based tests of animal longitudinal study; frontal, the overlap between the frontal ROI and the cluster in the
frontal region identified in a voxel-based test of an animal longitudinal study. MAM methylazoxymethanol acetate, ROI region of interest.
Fig. 4 Pathway characteristics of frontal-posterior functional imbalance in MAM rats. A Pathways of metabolomic profiles in the PFC
between vehicle rats and MAM rats. The metabolites are enriched in the central carbon metabolism pathway. B Pathways of metabolomic
profiles in the OC between vehicle rats and MAM rats. The metabolites are enriched in the central carbon metabolism pathway. C Pathways of
proteomic profiles in the prefrontal cortex between vehicle-sham rats and MAM-sham rats. The significant network was the “Alzheimer
disease pathway”. MAM methylazoxymethanol acetate, PFC prefrontal cortex, OC occipital cortex, KEGG Kyoto Encyclopedia of Genes and
Genomes.
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metabolism disturbance and mitochondrial dysfunction. The
understanding of the dynamic nature underlying SZ is crucial for
the development of effective therapies, which have significant
translational implications for SZ.
Frontal-posterior functional imbalance consisting of significantly
increased ReHo in higher-order frontal cortices and significantly
decreased ReHo in the posterior primary sensory cortices was
observed in both hSZ and MAM rats. Our previous studies have
shown a similar functional imbalance between frontal and
posterior regions with significantly increased ALFF and FC in the
prefrontal and orbitofrontal cortices, and significantly decreased
ALFF and FC in the primary sensory cortices in SZ [20, 33]. We have
also found disrupted balance in brain network segregation and
integration in SZ with significantly decreased short-range
connectivity in the primary sensory cortices and significantly
increased medium/long-range connectivity in the PFC [21]. A
recent meta-analysis study examining spatial and temporal
intrinsic brain activity in SZ found that alterations in ALFF/fALFF
and ReHo have a similar distribution in SZ, such as decreased
ALFF/fALFF and ReHo in the somatosensory, posterior parietal, and
occipital cortices, and increased ALFF/fALFF and ReHo in the
striatum, medial temporal and prefrontal cortices [34].
Furthermore, we found that MAM rats showed decreased
ReHo in the primary sensory cortices in adolescence. These
findings in adolescent MAM rats may relate to functional brain
alterations in clinical high-risk groups for SZ (CHR-SZ) or first-
degree relatives of hSZ. Studies have shown significantly
reduced ReHo in the right insula and right superior temporal
gyrus [35], as well as left inferior occipital gyrus [36], in first-
degree relatives of SZ individuals, compared to HC. Similarly,
functional brain changes with significantly decreased ALFF and
FC in the posterior sensory cortices were also found. CHR-SZ has
shown decreased FC of precuneus and visual association areas
[37], relative to HC. Moreover, significantly decreased ALFF in the
left inferior parietal lobule and postcentral gyrus have been
found in CHR-SZ compared to HC [38].
As SZ is a neurodevelopmental disorder, a major focus has
been to understand what brain changes and what regions, and
which time initiate the brain functional alterations that lead to
SZ. In this study, our results supported that the adolescent visual
cortex was a critical locus and a sensitive window in SZ
development based on the longitudinal data of brain function
changes from adolescence to adulthood in MAM rats. Adoles-
cence is considered as a time-sensitive window of brain
development, during which robust brain plasticity is exhibited
[39]. In adolescence, the chronological desynchronization of
spontaneous neuronal activity corresponds to the increased
sensory input signals, switching the factors most strongly to
drive the shaping and development of cortical networks [40].
Any changes in synaptic plasticity during adolescence have
long-lasting effects on brain function [41]. Moreover, primary
sensory cortices appear to have essential roles in brain
development. The development of primary sensory regions,
particularly regions concerning visual and auditory streams,
precedes and scaffolds higher-order regions structure and
function, like the PFC [42]. The dysfunction of primary sensory
regions could result in aberrant processing and translation of
afferent sensory inputs and a cascade of distinct events in the
higher-order regions, and thus inaccurate integration of sensory
signals and erroneous feedback within sensory processing
circuits lead to progressive and persistent disruptions within
the brain function in SZ [43, 44].
The potential mechanisms underlying frontal-posterior func-
tional imbalance are of significant interest as they could provide a
greater understanding of the biological changes of functional
alterations and facilitate treatment development for SZ. Central
carbon metabolism disturbance was detected in MAM rats. This
pathway mainly refers to the altered glucose metabolism, which
plays an essential role in the supply of biosynthetic precursors and
energy [45]. In our study, energy metabolism appeared altered in
the PFC and OC in MAM rats. The frontal-posterior functional
imbalance, induced by disturbed cerebral blood flow, may
indicate abnormal energy demand in response to abnormally
high glucose demand or insufficient glucose supply in regional
cortices [46]. The consumption of glucose resulted in an increase
of lactate levels [47], which was associated with oxidative stress,
dopamine reuptake inhibition, synaptic glutamate release, and
cognitive impairment, which is in line with SZ features [48–50].
Proteomic analyses implicated mitochondrial dysfunction in MAM
rats that could disrupt the bioenergetics in the developing brain
and lead to neurodevelopmental abnormalities [51]. Mitochondrial
function can disturb calcium homeostasis, which changes the
spontaneous neocortical activity and resting-state fMRI [52, 53].
Reduced or enhanced mitochondrial calcium uptake capacity
would decrease or increase spontaneous neuronal activity,
respectively [54]. Moreover, altered mitochondrial calcium home-
ostasis could lead to dopamine and glutamate system dysfunc-
tions, and thus ultimately affect synaptic plasticity and cortical
microcircuitry in SZ [55].
Several limitations should be noted. First, the anesthetic agents
used for MRI scanning may change neuronal functions and
neurovascular coupling. The potential confounding effects due to
anesthesia should have been minimized with comparison to
controls that were also anesthetized for scanning. Second, we do
not provide information about cellular changes involved in the
dynamic maturational processes of MAM rats, and therefore
further assessment of cellular changes from adolescence to
adulthood should be supplemented for comprehensive pheno-
typing. Third, although MAM rats are a validated animal model of
SZ, no single animal model can fully capture the complex
neurobiological and behavioral spectrum of SZ. Future studies
using additional preclinical models are needed for a more
comprehensive understanding of SZ.
In summary, based on our findings in hSZ and the neurode-
velopmental MAM rat model of SZ, the frontal-posterior functional
imbalance appears to be a significant feature in SZ, and likely
frontal-posterior functional imbalance undergoes aberrant devel-
opment from adolescent decreased posterior brain function
(visual and associated cortices) to adult increased frontal (frontal
cortices)-decreased posterior brain function. Further, metabolic
and proteomic changes in MAM rats suggest central carbon
metabolism disturbance and mitochondrial dysfunction as poten-
tial mechanisms of frontal-posterior functional imbalance in adult
SZ. These findings link data between humans and animal models
in SZ and may have a significant translational contribution to
effective neuromodulation in SZ. This work is the first of its kind
and will need further study and replication.
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